Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?

ABSTRACT:

SUBMITTER: Di Noia V 

PROVIDER: S-EPMC9548024 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature